Skip to main content

brimonidine

Generic: BRIMONIDINE TARTRATE·Brand: ALPHAGAN, ALPHAGAN P, BRIMONIDINE TARTRATE, LUMIFY, LUMIFY PRESERVATIVE FREE, Lumify, MIRVASO, QOLIANA

brimonidine: sourced relationships with 1 company · 1 clinical trial tracked · 1 FDA decision.

brimonidine evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect brimonidine to RDY; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could brimonidine → RDY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Dated Pipeline Records (1)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2024-02-16 · Current development: unknownSource
Approved
Clinical Trial Registry Records (1)

A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

NCT05656027Registry updated 2026-02-25·Phase 3·LENZ
Completed

Primary endpoint: Percentage of Participants With a ≥ 3-line Improvement in Near Vision and no Loss ≥ 5 Letters Distance Vision

InterventionalRandomizedquadruple469 enrolledStarted 2022-12Completion 2024-0125 sites · United StatesLENZ Therapeutics, Inc
FDA Decisions1 records
Approval(RDY)FDA ↗
ANDA216361UNKNOWNStandardOphthalmicSolution/Drops

Frequently asked questions

Which companies have sourced relationships with brimonidine?

brimonidine has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.

How many clinical trials involve brimonidine?

BioSniper tracks 1 clinical trial involving brimonidine.

What is brimonidine's latest FDA decision?

The most recent tracked FDA decision for brimonidine is Approval, dated February 16, 2024.